Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression.
about
Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cellsNon-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanismsNeuroendocrine differentiation in prostate cancerNeuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinaseInterleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells.Neuroendocrine differentiation: The mysterious fellow of colorectal cancerNeuroendocrine differentiation in prostate cancer: a mechanism of radioresistance and treatment failureβ-Adrenergic Receptor Signaling in Prostate CancerNeuroendocrine-derived peptides promote prostate cancer cell survival through activation of IGF-1R signaling.Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression.The neuroendocrine-derived peptide parathyroid hormone-related protein promotes prostate cancer cell growth by stabilizing the androgen receptor.Sphingosine kinase-1 is central to androgen-regulated prostate cancer growth and survival.Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle.Identification of a small molecule class to enhance cell-cell adhesion and attenuate prostate tumor growth and metastasis.Exposure to maternal obesogenic diet worsens some but not all pre-cancer phenotypes in a murine genetic model of prostate cancer.Impact of stress on cancer metastasispp32 reduction induces differentiation of TSU-Pr1 cells.Ionizing radiation induces neuroendocrine differentiation of prostate cancer cells in vitro, in vivo and in prostate cancer patientsEGF prevents the neuroendocrine differentiation of LNCaP cells induced by serum deprivation: the modulator role of PI3K/AktUp-Regulated Expression of LAMP2 and Autophagy Activity during Neuroendocrine Differentiation of Prostate Cancer LNCaP CellsOrigin of androgen-insensitive poorly differentiated tumors in the transgenic adenocarcinoma of mouse prostate model.Neuroendocrine influences on cancer progression.Sympathetic modulation of immunity: relevance to disease.LNCaP prostate cancer cells with autocrine interleukin-6 expression are resistant to IL-6-induced neuroendocrine differentiation due to increased expression of suppressors of cytokine signalingNeuroendocrine modulation of cancer progression.TRIIODOTHYRONINE ATTENUATES PROSTATE CANCER PROGRESSION MEDIATED BY β-ADRENERGIC STIMULATIONOncogenic activation of androgen receptor.GRK3 is a direct target of CREB activation and regulates neuroendocrine differentiation of prostate cancer cells.RNA interference of achaete-scute homolog 1 in mouse prostate neuroendocrine cells reveals its gene targets and DNA binding sites.Thyroid hormone-dependent epigenetic suppression of herpes simplex virus-1 gene expression and viral replication in differentiated neuroendocrine cells.The role of high cell density in the promotion of neuroendocrine transdifferentiation of prostate cancer cells.siRNA-mediated downregulation of TC21 sensitizes esophageal cancer cells to cisplatin.Interleukin-6: a bone marrow stromal cell paracrine signal that induces neuroendocrine differentiation and modulates autophagy in bone metastatic PCa cells.Cyr61 is regulated by cAMP-dependent protein kinase with serum levels correlating with prostate cancer aggressiveness.Snail transcription factor regulates neuroendocrine differentiation in LNCaP prostate cancer cells.Aberrant activation of androgen receptor in a new neuropeptide-autocrine model of androgen-insensitive prostate cancer.Establishment of a neuroendocrine prostate cancer model driven by the RNA splicing factor SRRM4.Protein kinase A-mediated phosphorylation of RhoA on serine 188 triggers the rapid induction of a neuroendocrine-like phenotype in prostate cancer epithelial cells.Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer.Targeting CREB inhibits radiation-induced neuroendocrine differentiation and increases radiation-induced cell death in prostate cancer cells.
P2860
Q24302096-37D9A4CB-BC6E-447D-AE33-ABF7F0905BFDQ24622202-0C98E342-CCC8-48FE-91D5-BC3773EA1BA5Q24657547-2D0DA7A6-661F-4972-B997-7D93EB6E1741Q24746249-16875544-8AC5-4212-A4B3-F30778CD4598Q24746259-372DDECD-18B2-435B-A26D-3346E060BA44Q26778012-C4A62267-3828-4492-9F1C-B67A7AB06D6EQ26859201-ECCF1DDD-3518-4FBE-A643-487D83960E7CQ28084943-7D31CB22-C2C2-40D7-88C0-653EDD60C00FQ30412002-9DB024C8-7852-413B-91EA-A160712EF80AQ30432236-FCEBDDFD-5A2E-4557-ABA6-8324E538A47CQ30434799-CAE453E6-51E7-4595-BE5F-5CDA21749C12Q30940949-78985108-19D3-489B-8E76-D41FCEF1373CQ33356928-43BCA51F-7293-499E-A3E2-BE3FE9585E60Q33416683-0004B148-7FE7-4E9E-9E61-5DDBE610963CQ33657727-408C9512-144E-4DB9-BB51-E9846FD8820FQ34569251-D0FB0676-C784-44C6-913E-78C05CEAF0A2Q35083306-F57DE618-B364-4930-9ADB-1FC15B19D5FCQ35380936-F8B62495-6FE9-4DE9-9AEC-6A613584EB5FQ35945055-95521F7C-6B47-49F1-84E4-C1DE9B0730C7Q36132777-C29BA546-6897-472A-8318-EAC86FC45350Q36143611-281504F3-8A0A-45F6-9DE9-5EC807888BAAQ36306358-D16817D8-748F-412C-8223-D4F91A42442AQ36552147-B2E134BA-04F3-4307-B80A-7651494B7276Q36879620-C606AA98-5A14-4BE4-A2DC-25F11C717B59Q37071784-F637913E-2E42-4C49-AE55-28C244E0CF9BQ37216993-1C0982A6-408D-44A2-91A2-DE953DE2CBFCQ37359265-25FFF556-29BB-43CF-A821-F853F75A1674Q37564369-FF823054-F78E-4D3E-A6CD-2570C273A293Q37682012-D909A0F8-79AF-4BF5-97B4-B11CC9210655Q38961062-846DDBAE-2BB8-455E-8B26-3A4450D68933Q38989505-A3D30998-09B0-4E14-84BD-9ACF25CFA58DQ39291729-A42745D8-8E0B-4A8E-AD9C-B9D37E4B6D33Q39375270-67CA8647-E46F-4309-9CFA-6C0D39C45937Q39453245-3D43BC54-C24C-4A86-B86C-0266841B4183Q39737891-DD638809-9E24-4233-AED8-C8A36211AAFAQ39899689-45FB0CFB-C81E-4006-BB18-68889ADEF0BDQ42071191-C3068930-349C-474A-8D03-823170316F8FQ42370539-22284038-8F6A-468D-8A59-280DF6125CD1Q42593140-CFFD0C3A-50FF-4BD1-9E80-5C121CB7D904Q42650664-BB4EA68D-739B-464E-AC17-E74F4FE25C95
P2860
Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Acquisition of neuroendocrine ...... r prostate cancer progression.
@ast
Acquisition of neuroendocrine ...... r prostate cancer progression.
@en
type
label
Acquisition of neuroendocrine ...... r prostate cancer progression.
@ast
Acquisition of neuroendocrine ...... r prostate cancer progression.
@en
prefLabel
Acquisition of neuroendocrine ...... r prostate cancer progression.
@ast
Acquisition of neuroendocrine ...... r prostate cancer progression.
@en
P2093
P1433
P1476
Acquisition of neuroendocrine ...... r prostate cancer progression.
@en
P2093
P304
P407
P577
1999-08-01T00:00:00Z